| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |